Research programme: inhaled therapeutics - Alexza PharmaceuticalsAlternative Names: AZ-008; AZ-009; Ropinirole inhalation - Alexza
Latest Information Update: 14 Jul 2010
At a glance
- Originator Alexza Pharmaceuticals
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 14 Jul 2010 Preclinical development is ongoing USA
- 09 May 2007 Preclinical trials in Insomnia in USA (Inhalation)